Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Oluwatoyin I, Ameh"'
Autor:
Bingileki F Lwezaula, Oluwatoyin I Ameh, Udeme E Ekrikpo, Francois CJ Botha, Ugochi S Okpechi-Samuel, Nicola Wearne, Pierre Ronco, Aminu K Bello, Ikechi G. Okpechi
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background: Serum and tissue-based tests using phospholipase A2 receptor 1 (PLA2R) and thrombospondin type-1 domain containing 7A (THSD7A) are established immune biomarkers for the diagnosis of primary membranous nephropathy (PMN). This stud
Externí odkaz:
https://doaj.org/article/41a87cfa91a64dc4b964a250e88d6db6
Publikováno v:
Kidney International Reports, Vol 5, Iss 3, Pp 255-262 (2020)
The epidemiologic transition occurring in low- and middle-income countries (LMICs) has led to a surge in chronic kidney disease (CKD) prevalence because of a combination of highly prevalent chronic noncommunicable diseases (NCDs) and communicable dis
Externí odkaz:
https://doaj.org/article/dbcf8e893f2445078171f207dce6807c
Autor:
Ikechi G. Okpechi, Oluwatoyin I. Ameh
Publikováno v:
European Medical Journal Nephrology, Vol 6, Iss 1, Pp 65-73 (2018)
Glomerular diseases are a common cause of chronic kidney disease in several low-to-middle-income countries (LMIC). Additionally, they represent up to 52% of patients with end-stage renal disease (ESRD) in Africa. Current guideline recommendations for
Externí odkaz:
https://doaj.org/article/39e906d6a4eb4a3b85ccefaeb5862a88
Autor:
Oluwatoyin I. Ameh, Muhammad A. Makusidi, Aminu M. Sakajiki, Hamidu M. Liman, Ikechi G. Okpechi
Publikováno v:
Evidence‐Based Nephrology. :658-670
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78246a1b7c0b6b10945db54c3d173fd3
https://doi.org/10.1002/9781119105954.ch38
https://doi.org/10.1002/9781119105954.ch38
Publikováno v:
Management of Kidney Diseases ISBN: 9783031091308
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::819ff7495706a5a66c7229f72fd53b72
https://doi.org/10.1007/978-3-031-09131-5_18
https://doi.org/10.1007/978-3-031-09131-5_18
Publikováno v:
International Journal of Nephrology and Renovascular Disease. 13:239-251
The incidence and prevalence of chronic kidney disease (CKD) and kidney failure continues to increase worldwide, especially in resource-limited countries. Many countries in this category already have a massive burden of communicable diseases, as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff6cd0b4e1c2b3daf55e67ba511fc1a
https://doi.org/10.2147/ijnrd.s242235
https://doi.org/10.2147/ijnrd.s242235
Autor:
Olalekan Olatise, Martin C. Igbokwe, Sadiq Abu, Adegboyega E. Faponle, Oluwatoyin I. Ameh, Stephen O. Asaolu, Michael O. Muoka
Publikováno v:
Transplantation. 106:S703-S704
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9684b33b0b08d47a76bce44dd809ce21
https://doi.org/10.1097/01.tp.0000889480.41115.83
https://doi.org/10.1097/01.tp.0000889480.41115.83
Autor:
Ramon A Tamayo Isla, Oluwatoyin I Ameh, Darlington Mapiye, Charles R Swanepoel, Aminu K Bello, Andrew R Ratsela, Ikechi G Okpechi
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156642 (2016)
Dialysis therapy for end-stage renal disease (ESRD) continues to be the readily available renal replacement option in developing countries. While the impact of rural/remote dwelling on mortality among dialysis patients in developed countries is known
Externí odkaz:
https://doaj.org/article/a7ee1b5a7712445eab631c922ab203b4
Autor:
Ikechi G Okpechi, Oluwatoyin I Ameh, Aminu K Bello, Pierre Ronco, Charles R Swanepoel, Andre P Kengne
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152203 (2016)
BACKGROUND AND AIM:Glomerulonephritis (GN) is a leading cause of end-stage renal disease (ESRD) in Africa. Data on epidemiology and outcomes of glomerular diseases from Africa is still limited. We conducted a systematic review on the epidemiology of
Externí odkaz:
https://doaj.org/article/5dd459db1454485fb69ce7d83ead3136
Autor:
Ugochi S. Okpechi-Samuel, Pierre Ronco, Nicola Wearne, Ikechi G. Okpechi, Aminu K. Bello, Francois Cj Botha, Oluwatoyin I. Ameh, Bingileki F Lwezaula, Udeme E. Ekrikpo
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Background: Serum and tissue-based tests using phospholipase A2 receptor 1 (PLA2R) and thrombospondin type-1 domain containing 7A (THSD7A) are established immune biomarkers for the diagnosis of primary membranous nephropathy (PMN). This study assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e341674aaa5d6d69af138759976c23
http://europepmc.org/articles/PMC7791976
http://europepmc.org/articles/PMC7791976